Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2025-01-05T12:32:25.856Z Has data issue: false hasContentIssue false
  • English
  • Français

The Mechanism of Drug-induced Akathisia

Published online by Cambridge University Press:  01 January 2011

Anton J.M. Loonen  and
Stephen M. Stahl
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Trends in Psychopharmacology
Information
CNS Spectrums , Volume 16 , Issue 1 , January 2011 , pp. 7 - 10
Copyright
Copyright © Cambridge University Press 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Faculty Disclosures: Dr. Stahl has served as a consultant to Allergan, AstraZeneca, BioMarin, BioVail, Boehringer-Ingelheim, Bristol-Myers Squibb, Cenerex, Covance, Cypress Bioscience, Dianippon, Eisai, Eli Lilly, Forest pharmaceuticals, GlaxoSmithKline, Labopharm, Lundbeck, Marinus, Meda Corp, Meiji, Merck, Novartis, Pfizer, Pfizer Canada, Pierre Fabre, Pamlab, Prexa, Propagate Pharma, Royalty Pharma, sanofi-aventis, Schering Plough, Shire, SK Corporation, Soffinova, Solvay, Vanda, and Wyeth; has served on speaker's bureaus of Pfizer, Schering Plough, and Wyeth; and has received grant support from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Cephalon, Dainippon, Eli Lilly, Forest pharmaceuticals, Lundbeck, Novartis, Pamlab, Pfizer, Pfizer Canada, Pharmasquire, sanofi-aventis, Schering Plough, Shire, and Wyeth.

References

Faculty Disclosures: Dr. Stahl has served as a consultant to Allergan, AstraZeneca, BioMarin, BioVail, Boehringer-Ingelheim, Bristol-Myers Squibb, Cenerex, Covance, Cypress Bioscience, Dianippon, Eisai, Eli Lilly, Forest pharmaceuticals, GlaxoSmithKline, Labopharm, Lundbeck, Marinus, Meda Corp, Meiji, Merck, Novartis, Pfizer, Pfizer Canada, Pierre Fabre, Pamlab, Prexa, Propagate Pharma, Royalty Pharma, sanofi-aventis, Schering Plough, Shire, SK Corporation, Soffinova, Solvay, Vanda, and Wyeth; has served on speaker's bureaus of Pfizer, Schering Plough, and Wyeth; and has received grant support from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Cephalon, Dainippon, Eli Lilly, Forest pharmaceuticals, Lundbeck, Novartis, Pamlab, Pfizer, Pfizer Canada, Pharmasquire, sanofi-aventis, Schering Plough, Shire, and Wyeth.